Investigation of the Effect of Information on the Empowerment of Cancer Patients Using Question Prompt List: A Mixed Method Study

NCT06903390 | Completed

• 1 other identifier: 09.2022.953
• Study Type: interventional
• Target: 96
• Locations: 1 country
• Sites: 1

Brief Summary

Brief Summary The goal of this study is to understand how patient empowerment and a Question Prompt List (QPL) can help cancer patients. The main questions this study aims to answer are: What are the views of nurses, physicians, and cancer patients on patient empowerment? Does using a Question Prompt List (QPL) improve patient empowerment and reduce anxiety? Researchers will collect qualitative and quantitative data by measuring patient empowerment and anxiety levels. Who can participate? Cancer patients receiving treatment at Private Anadolu Medical Center Hospital Nurses and physicians working with cancer patients What will participants do? Answer survey questions about their experiences with empowerment, anxiety, and communication Participate in interviews to share their thoughts on patient empowerment Use a Question Prompt List (QPL) during medical consultations Why is this study important? Many cancer patients struggle with anxiety and lack of information about their care. A Question Prompt List (QPL) may help patients ask better questions, feel more in control of their treatment, and reduce anxiety. This study will contribute to oncology research and help develop a culture-specific QPL for use in cancer care. This study will take place at Private Anadolu Medical Center Hospital from January 2023 to November 2024.

Conditions

Neoplasms (Cancer / Tumors); Patient Participation; Patient-Centered Care; Health Communication; Patient Empowerment; Anxiety

Outcome Measures

Primary Outcomes (2)

• Change in Patient Empowerment Score

  Assessed using the Patient Empowerment Scale to evaluate the effect of QPL-based communication on patient empowerment compared to standard communication. Higher scores indicate greater empowerment.

  Immediately before the first consultation and within 1 day after the second and third consultations

• Change in Anxiety Level (HADS)

  Measured using the Hospital Anxiety and Depression Scale (HADS) to assess changes in anxiety levels resulting from QPL-based communication versus standard communication. Lower scores indicate lower anxiety.

  Immediately before the first consultation and within 1 day after the second and third consultations

Study Arms (2)

"QPL vs. standard care to assess impact on patient empowerment & anxiety in cancer patients.

EXPERIMENTAL

Experimental Group 1 (QPL Communication Intervention Group) Participants in this group will receive a structured communication intervention using the Quick Question List (QPL) during their oncology examinations. The QPL aims to enhance patient empowerment, encourage active participation, and improve communication between patients and healthcare providers. It is designed to help patients express their concerns effectively and engage more actively in their care process. Intervention: Implementation of a QPL-based communication strategy in addition to standard oncology care.

Behavioral: QPL-based Communication Intervention

Standard Care Group

NO INTERVENTION

Participants in this group will receive standard physician-patient communication without any additional intervention. This group serves as a control group to evaluate the effectiveness of the QPL-based communication intervention. Intervention: No additional communication tools or interventions will be applied. Patients will receive routine oncology consultations with standard physician-patient interactions.

Interventions

QPL-based Communication Intervention BEHAVIORAL

This QPL-based communication intervention stands out with the following key features: Patient-Centered \& Cancer-Specific QPL: The intervention uses a QPL tailored for cancer patients, culturally adapted to enhance empowerment and manage anxiety. Structured Training \& Support: Patients receive training before consultations, with additional guidance for effective QPL use at subsequent visits. Multiple Assessment Points: The QPL's impact is measured after the first, second, and third consultations, allowing for longitudinal evaluation. RCT Design: This study is a randomized controlled trial (RCT), comparing the intervention group (QPL) to a control group receiving standard care. Focus on Empowerment \& Anxiety: Unlike prior studies, this intervention focuses on empowering patients and reducing anxiety, with outcomes measured through validated scales (Patient Empowerment Scale and HADS). These features differentiate this intervention by offering a structured, culturally relevant approach.

"QPL vs. standard care to assess impact on patient empowerment & anxiety in cancer patients.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients must be over 18 years old.
• Must understand and speak Turkish.
• Must not have any condition preventing participation (e.g., advanced dementia, cognitive impairment, speech or hearing disorders).
• For healthcare professionals in the qualitative phase: Must have at least one year of experience in oncology.

You may not qualify if:

• Patients without regular outpatient follow-up visits.
• Patients with severe cognitive or physiological deterioration affecting participation.
• Patients who do not comply with the study process and requirements.
• Patients who voluntarily request to withdraw from the study.

Sponsors & Collaborators

• Marmara University: lead

Study Sites (1)

Marmara Üniversitesi

Istanbul, Kadıköy, 34722, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Neoplasms; Patient Participation; Anxiety Disorders

Condition Hierarchy (Ancestors)

Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior; Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Masking Details: This study follows an open-label design, meaning that participants, care providers, and investigators are aware of the assigned intervention. Masking Description: Since this study involves a communication-based intervention, blinding is not feasible, as both participants and care providers are directly involved in delivering and receiving the intervention.
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PhD Student, Principal Investigator

Model Details: This study is a parallel-group randomized controlled trial designed to assess the impact of QPL-based communication intervention on patient empowerment and anxiety levels in cancer patients. Participants are assigned to either the intervention group (QPL-based communication) or the control group (standard physician-patient communication).

Study Record Dates

• First Submitted: March 19, 2025
• First Posted: March 30, 2025
• Study Start: March 1, 2024
• Primary Completion: March 1, 2025
• Study Completion: March 1, 2025
• Last Updated: December 10, 2025

Record last verified: 2024-03

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)